Recent advances in diagnosis and treatment of pheochromocytoma

Minerva Medica

Volumn 94, Issue 4, 2003, Pages 267-271

  Veglio, F ^a,b   Morello, F ^a   Morra Di Cella, S ^a   Del Colle, S ^a   Rabbia, F ^a   Mulatero, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Ospedale San Vito   (Italy)

Author keywords

Catecholamines; Hypertension; Pheochromocytoma

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CHROMOGRANIN A; CLONIDINE; DIHYDROPYRIDINE DERIVATIVE; DOXAZOSIN; LABETALOL; METADRENALIN; METIROSINE; NIFEDIPINE; PHENOXYBENZAMINE; PHENTOLAMINE;

ADRENAL MEDULLA; ANXIETY; CANCER STAGING; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE EXCRETION; CHROMAFFIN CELL; CLINICAL FEATURE; CLONIDINE SUPRESSION TEST; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; GENETIC DISORDER; HEADACHE; HEART PALPITATION; HYPERKINESIA; HYPERTENSION; HYPERTENSIVE CRISIS; LAPAROSCOPIC SURGERY; MORTALITY; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE II; NAUSEA; NERVOUSNESS; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLOR; PHEOCHROMOCYTOMA; REVIEW; SENSITIVITY AND SPECIFICITY; SYNDROME DELINEATION; TACHYCARDIA; TUMOR LOCALIZATION; VOMITING; WEIGHT REDUCTION;

ADRENAL GLAND NEOPLASMS; ALGORITHMS; HUMANS; PHEOCHROMOCYTOMA;

EID: 0242526770     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Lenz T, Gossman J, Schulte KL, Salewski L, Geiger H. Diagnosis of pheochromocytoma. Clin Lab 2002;48:5-18.
2. Ross J. Pheochromocytoma, special considerations in children. Ped Urol Oncology 2000;27:393-402.
3. Neumann HPH, Bausch B, McWinney SR, Bender BU, Gimm O, Franke KE et al. Germ-line mutations in non-syndromic pheochromocytoma. N Engl J Med 2002; 346:1459-66.
4. Phillips RA. Pheochromocytoma. How to diagnose, how to treat. J Clin Hypertens 2002;1:62-72.
5. Pacak K. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Inter Med 2001;134:315-29.
6. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C et al. Guidelines for diagnosis and therapy of MEN type I and type 2. J Clin End Metab 2001;86:5658-71.
7. Neumann HPH, Hoegerle S, Manz T, Brenner K, Iliopoulos O. How many pathways to pheochromocytoma? Semin Nephrol 2002;22:89-99.
8. Lenders JWM, Pacak K, McClellan M, MLinehan WM, Mannelli M, Friberg P et al. Biochemical diagnosis of pheochromocytoma. Which test is best? JAMA 2002;1427-34.
9. Sawka AM, Jaeschke R, Ravinder JS, Young WF. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003;88:553-8.
10. Taupenot L, Harper KL, O'Connor DT. The chromogranin-secretogranin family. N Engl J Med 2003;3348: 1134-49.
11. Sjoberg RJ, Simeie KJ, Kidd GS. The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. Arch Intern Med 1992;152:1193-7.
12. Francis IR, Korobkin M. Pheochromocytoma. Radiol Clin North Am 1996;34:1101-12.
13. Sisson JC, Shulkin BL. Nuclear medicine imaging of pheochromocytoma and neuroblastoma. Q J Nucl Med 1996;40:365-71.
14. Hoegerle S, Nitzsche E, Altehofer C, Ghanem N, Manz T, Brink I et al. Pheochromocytomas: detection with 18FDOPA whole-body PET-initial results. Radiology 2002;222:507-12.
15. Walther MM, Keiser HR, Linehan WM. Pheochromocytoma: evaluation, diagnosis and treatment. World J Urol 1999;17:35-9.